Clinical Trials
11 trialsNCT07192926 2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
NCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
NCT05197504 2025-09-05
HCC
CHA University
Completed
NCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT04920981 2024-11-07
CLINATEZO
Intergroupe Francophone de Cancerologie Thoracique
Completed
NCT06169904 2023-12-14
B7-Family Score in Urothelial Carcinoma
Shanghai Zhongshan Hospital
Completed
NCT03559647 2023-09-01
The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy
Hoffmann-La Roche
Completed
NCT03330886 2023-03-13
A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina
Hoffmann-La Roche
Completed
NCT05609903 2022-11-08
Anastase
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
NCT03232593 2022-08-24
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
Hoffmann-La Roche
Completed
NCT03790397 2022-06-03
OSIREX
Fundación GECP
Completed